Literature DB >> 25977302

Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.

Harmony R Reynolds1, Michael H Picard2, Judith S Hochman2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25977302      PMCID： PMC4477959          DOI： 10.1161/CIRCIMAGING.113.000362

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  48 in total

1.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

2.  Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).

Authors:  Rory Hachamovitch; Benjamin Nutter; Mark A Hlatky; Leslee J Shaw; Michael L Ridner; Sharmila Dorbala; Rob S B Beanlands; Benjamin J W Chow; Elizabeth Branscomb; Panithaya Chareonthaitawee; W Guy Weigold; Szilard Voros; Suhny Abbara; Tsunehiro Yasuda; Jill E Jacobs; John Lesser; Daniel S Berman; Louise E J Thomson; Subha Raman; Gary V Heller; Adam Schussheim; Richard Brunken; Kim A Williams; Susan Farkas; Dominique Delbeke; Uwe J Schoepf; Nathaniel Reichek; Stuart Rabinowitz; Steven R Sigman; Randall Patterson; Carolyn R Corn; Richard White; Ella Kazerooni; James Corbett; Sabahat Bokhari; Josef Machac; Erminia Guarneri; Salvador Borges-Neto; John W Millstine; James Caldwell; James Arrighi; Udo Hoffmann; Matthew Budoff; Joao Lima; James R Johnson; Barbara Johnson; Mariya Gaber; Julie A Williams; Courtney Foster; Jon Hainer; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2012-01-31       Impact factor: 24.094

3.  Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.

Authors:  Gilles R Dagenais; Jiang Lu; David P Faxon; Kenneth Kent; Rodrigo M Lago; Carlos Lezama; Whady Hueb; Melvin Weiss; James Slater; Robert L Frye
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

4.  Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.

Authors:  Gilles R Dagenais; Jiang Lu; David P Faxon; Peter Bogaty; Dale Adler; Francisco Fuentes; Jorge Escobedo; Ashok Krishnaswami; James Slater; Robert L Frye
Journal:  J Am Coll Cardiol       Date:  2013-02-19       Impact factor: 24.094

5.  Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT.

Authors:  Leslee J Shaw; James K Min; Rory Hachamovitch; Robert C Hendel; Salvador Borges-Neto; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2011-11-02       Impact factor: 5.952

6.  Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.

Authors:  Leslee J Shaw; William S Weintraub; David J Maron; Pamela M Hartigan; Rory Hachamovitch; James K Min; Marcin Dada; G B John Mancini; Sean W Hayes; Robert A O'Rourke; John A Spertus; William Kostuk; Gilbert Gosselin; Bernard R Chaitman; Merill Knudtson; John Friedman; Piotr Slomka; Guido Germano; Eric R Bates; Koon K Teo; William E Boden; Daniel S Berman
Journal:  Am Heart J       Date:  2012-08       Impact factor: 4.749

7.  Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Authors:  Leslee J Shaw; Manuel D Cerqueira; Maria M Brooks; Andrew D Althouse; Veronica V Sansing; George A Beller; Rodica Pop-Busui; Raymond Taillefer; Bernard R Chaitman; Raymond J Gibbons; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-04-19       Impact factor: 5.952

8.  Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction.

Authors:  Julio A Panza; Thomas A Holly; Federico M Asch; Lilin She; Patricia A Pellikka; Eric J Velazquez; Kerry L Lee; Salvador Borges-Neto; Pedro S Farsky; Robert H Jones; Daniel S Berman; Robert O Bonow
Journal:  J Am Coll Cardiol       Date:  2013-03-07       Impact factor: 24.094

9.  Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization.

Authors:  Nael Aldweib; Kazuaki Negishi; Rory Hachamovitch; Wael A Jaber; Sinziana Seicean; Thomas H Marwick
Journal:  J Am Coll Cardiol       Date:  2013-04-16       Impact factor: 24.094

10.  Patient outcome following 2 different stress imaging approaches: a prospective randomized comparison.

Authors:  Thomas R Porter; Lynette M Smith; Juefei Wu; Deepak Thomas; John T Haas; Daniel H Mathers; Eric Williams; Joan Olson; Kevin Nalty; Roberta Hess; Stacey Therrien; Feng Xie
Journal:  J Am Coll Cardiol       Date:  2013-05-02       Impact factor: 24.094
View more
  3 in total

1.  Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD : For prime time not yet: Need impact and certainty.

Authors:  Heinrich Schelbert
Journal:  J Nucl Cardiol       Date:  2017-04-10       Impact factor: 5.952

2.  ISCHEMIA, to revascularize or not to revascularize.

Authors:  Faraz Kureshi; Mouin S Abdallah
Journal:  J Nucl Cardiol       Date:  2016-06-08       Impact factor: 5.952

3.  Nuclear Cardiology in 2020 - Perspectives of the New SBC Guideline.

Authors:  Cláudio Tinoco Mesquita; Wilter Dos Santos Ker; Jader Cunha de Azevedo
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.